{"originalText": "，1+年前患者因“子宫内膜癌I期”于2012-08-10日全麻上行全子宫及两侧附件切除术，，术后病检结果提示：1、高-中分化子宫内膜样腺癌。患者术后无阴道流血、流液，无明显腹痛、腹胀，无恶心、呕吐，无咳嗽、咳痰等不适。患者定期我院门诊复查，提示CA125升高及盆腔积液，考虑肿瘤复发，于2013-7-15收入院行第一次化疗（紫杉醇180MG+奥沙利铂180MG），化疗期间及化疗出院后患者偶有腹泻。于2013-8-15查子宫内膜癌标记物提示，CA125：148.6U/ L,，组织多肽抗原：110U/L,行第二次化疗（紫杉醇180MG+奥沙利铂180MG），有轻微恶心、呕吐等不适，无腹痛、黑便、呕血，无骨痛、皮疹，无阴道流血、流液等不适。现患者要求第3次化疗，遂以“子宫内膜癌第3次化疗”收入住院。 \\U0004   患者本次发病以来，食欲减退， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 9, "end_pos": 16}, {"end_pos": 44, "label_type": "手术", "overlap": 0, "start_pos": 33}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 57, "end_pos": 69}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 87, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 122, "end_pos": 127}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 130, "end_pos": 134}, {"end_pos": 165, "label_type": "药物", "overlap": 0, "start_pos": 162}, {"end_pos": 175, "label_type": "药物", "overlap": 0, "start_pos": 171}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 210, "end_pos": 215}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 221, "end_pos": 226}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 238, "end_pos": 244}, {"end_pos": 262, "label_type": "药物", "overlap": 0, "start_pos": 259}, {"end_pos": 272, "label_type": "药物", "overlap": 0, "start_pos": 268}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 292}, {"end_pos": 303, "label_type": "解剖部位", "overlap": 0, "start_pos": 302}, {"end_pos": 311, "label_type": "解剖部位", "overlap": 0, "start_pos": 309}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 334, "end_pos": 339}]}
